Nalaganje...
Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?
Significant research has been conducted to better understand the extensive, heterogeneous molecular features of triple-negative breast cancer (TNBC). We reviewed published TNBC molecular classifications to identify major groupings that have potential for clinical trial development. With the ultimate...
Shranjeno v:
| izdano v: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Impact Journals LLC
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4536987/ https://ncbi.nlm.nih.gov/pubmed/25973541 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|